Health & Wellbeing

Treatment for Cushing's Disease in Dogs: A Complete Veterinary Guide

Guide to treatment for Cushing's disease in dogs — symptoms, diagnosis costs, medications like trilostane, surgery options, and prognosis data.

By Marcus Aldridge · Published 11 September 2026
Treatment for Cushing's Disease in Dogs: A Complete Veterinary Guide

Cushing's disease (hyperadrenocorticism) is an endocrine disorder caused by chronic overproduction of cortisol, the body's primary stress hormone. In dogs, it most commonly results from a benign pituitary tumor that signals the adrenal glands to pump out excess cortisol. Less frequently, an adrenal tumor or prolonged use of steroid medications triggers the condition. According to the Merck Veterinary Manual, pituitary-dependent hyperadrenocorticism (PDH) accounts for approximately 80–85% of naturally occurring cases, while adrenal tumors (AT) cause roughly 15–20%. Iatrogenic Cushing's — caused by long-term corticosteroid administration — is also seen in clinical practice. The disease primarily strikes middle-aged to older dogs, typically between 7 and 12 years of age, and affects an estimated 1 to 2 out of every 1,000 dogs annually.

Left untreated, Cushing's disease progressively damages organ systems, leading to diabetes, hypertension, recurrent infections, and eventually organ failure. The good news: modern veterinary medicine offers multiple effective treatment pathways, and most dogs achieve meaningful symptom control with proper management.

What Is Cushing's Disease in Dogs?

Cushing's disease — formally known as hyperadrenocorticism — occurs when a dog's body produces too much cortisol over an extended period. Cortisol is essential for regulating metabolism, immune response, and stress adaptation, but chronic excess causes widespread physiological disruption.

There are three recognized forms:

  • Pituitary-Dependent Hyperadrenocorticism (PDH): A benign tumor (adenoma) on the pituitary gland overproduces adrenocorticotropic hormone (ACTH), which overstimulates both adrenal glands. This accounts for 80–85% of cases.
  • Adrenal Tumor (AT): A tumor on one adrenal gland autonomously secretes cortisol independent of pituitary signaling. These may be benign (adenoma) or malignant (adenocarcinoma), each comprising roughly half of adrenal-origin cases.
  • Iatrogenic Cushing's: Caused by prolonged administration of corticosteroid medications (e.g., prednisone, dexamethasone) used to treat allergies, autoimmune conditions, or inflammatory diseases.
Key distinction: PDH affects both adrenal glands (bilateral enlargement), while an adrenal tumor typically causes one enlarged gland and one atrophied gland. This distinction directly determines which treatment protocol your veterinarian will recommend.

Symptoms of Cushing's Disease: Early Warning Signs vs. Advanced Indicators

Cushing's disease is notoriously insidious — symptoms develop gradually over months or even years, and many owners initially attribute changes to normal aging. Recognizing the progression pattern is critical for early intervention.

Severity Stage Symptoms What Owners Typically Notice
Early / Mild Increased thirst (polydipsia), increased urination (polyuria), increased appetite (polyphagia) Water bowl empties faster; more frequent potty breaks or indoor accidents; dog seems constantly hungry
Early / Mild Mild hair thinning, especially along the trunk and flanks Coat looks less full; slower regrowth after grooming or shedding season
Moderate Pot-bellied appearance (abdominal distension), muscle wasting along the spine and limbs Dog looks like it gained weight in the belly but feels bony along the back; "tucked up" appearance
Moderate Bilateral symmetric alopecia (hair loss on both sides of the body), thinning skin, darkened skin patches (hyperpigmentation) Visible bald patches that are symmetrical; skin feels paper-thin or bruises easily; dark spots on belly
Moderate Recurrent skin infections, ear infections, urinary tract infections Infections that keep coming back despite treatment; yeast overgrowth on skin
Advanced / Severe Lethargy, exercise intolerance, panting at rest, calcinosis cutis (hard calcium deposits in skin) Dog reluctant to walk or play; gritty or hard lumps under the skin; heavy breathing without exertion
Advanced / Severe Neurological signs: disorientation, head pressing, seizures, pacing (indicative of macroadenoma) Dog seems confused, walks in circles, presses head against walls — this is an emergency
Advanced / Severe Diabetes mellitus, hypertension, pancreatitis, pulmonary thromboembolism (blood clots in lungs) Sudden collapse, severe vomiting, acute vision changes — these comorbidities significantly worsen prognosis

The classic "textbook" presentation — a middle-aged dog with increased drinking, urination, appetite, a pot belly, and hair loss — is seen in many but not all cases. Some dogs present with only one or two symptoms, which is why veterinary diagnostic testing is essential.

Risk Factors: Which Dogs Are Most Likely to Develop Cushing's Disease?

Breed Predisposition & Risk Profile

Highest-risk breeds (PDH): Poodles (especially Miniature and Standard), Dachshunds, Boston Terriers, Yorkshire Terriers, Beagles, Bichon Frises, German Shepherds

Highest-risk breeds (Adrenal Tumors): Larger breeds show higher incidence — German Shepherds, Poodles, Dachshunds, Yorkshire Terriers, and Labrador Retrievers

Age: Most commonly diagnosed between 7–12 years; rare in dogs under 6 years

Sex: Females are slightly more predisposed than males (approximately 60:40 ratio for PDH); adrenal tumors show a stronger female bias

Size: PDH occurs across all sizes but is overrepresented in small-to-medium breeds; adrenal tumors are somewhat more common in dogs over 44 lb (20 kg)

Medication history: Any dog receiving long-term corticosteroid therapy (oral, injectable, or topical) is at risk for iatrogenic Cushing's

Genetics clearly play a role — certain family lines within predisposed breeds show higher incidence. However, no genetic test currently screens for Cushing's disease risk. Environmental factors are not strongly linked, though obesity can complicate diagnosis and worsen outcomes.

How Is Cushing's Disease Diagnosed in Dogs?

Diagnosing Cushing's disease requires a deliberate, multi-step process. No single test is definitive on its own, and false positives are common in dogs with other illnesses. Your veterinarian will typically follow a staged diagnostic protocol:

Diagnostic Process Flowchart

  1. Step 1 — Clinical Suspicion: Veterinarian observes compatible symptoms and reviews history. Initial blood work (CBC and chemistry panel) reveals supporting clues: elevated alkaline phosphatase (ALP), elevated ALT, stress leukogram (high neutrophils, low lymphocytes/eosinophils), and dilute urine (low specific gravity).
  2. Step 2 — Screening Tests (confirming hyperadrenocorticism):
    • Low-Dose Dexamethasone Suppression Test (LDDST): Blood is drawn at 0, 4, and 8 hours after a low dose of dexamethasone is injected. In healthy dogs, cortisol suppresses; in Cushing's dogs, it does not. Sensitivity: ~95% for PDH. Cost: $150–$300.
    • Urine Cortisol:Creatinine Ratio (UCCR): A home-collected morning urine sample screens for elevated cortisol. This is a high-sensitivity, low-specificity test — a normal result effectively rules out Cushing's, but an elevated result requires further testing. Cost: $50–$100.
    • ACTH Stimulation Test: Measures adrenal reserve by checking cortisol before and after synthetic ACTH injection. More commonly used to monitor treatment but can aid diagnosis. Sensitivity: ~80% for PDH, ~95% for adrenal tumors. Cost: $150–$250.
  3. Step 3 — Differentiating Test (PDH vs. Adrenal Tumor):
    • High-Dose Dexamethasone Suppression Test (HDDST): A higher dose of dexamethasone suppresses cortisol in ~75% of PDH dogs but not in adrenal tumor cases. Cost: $150–$300.
    • Endogenous ACTH Concentration: Measures the dog's own ACTH levels — high in PDH, low/undetectable in adrenal tumors. Requires specialized lab processing and careful sample handling (must be frozen immediately). Cost: $100–$200.
  4. Step 4 — Imaging:
    • Abdominal Ultrasound: Evaluates adrenal gland size and shape. Bilateral enlargement supports PDH; unilateral enlargement with contralateral atrophy supports an adrenal tumor. Also checks for liver changes and other abdominal pathology. Cost: $300–$600.
    • CT or MRI of the Brain: Recommended if neurological signs are present or if a pituitary macroadenoma (tumor >10 mm) is suspected. Essential before radiation therapy. Cost: $1,000–$2,500.

Total diagnostic cost range: Expect to spend $600–$1,500 for a complete diagnostic workup (Steps 1–3 with ultrasound). Add $1,000–$2,500 if advanced brain imaging is needed. These ranges vary by geographic region and whether you see a general practitioner or a veterinary internal medicine specialist.

Treatment Options for Cushing's Disease in Dogs

Can Cushing's disease be cured? The answer depends on the form. Most cases of PDH are managed (not cured) with lifelong medication. Adrenal tumors may be curable with surgery if the tumor is benign and has not metastasized. Iatrogenic Cushing's resolves with a carefully tapered withdrawal of the offending steroid.

Below is a detailed comparison of treatment options, including the medications, procedures, and outcomes your veterinarian may discuss with you.

Treatment Type Used For Mechanism Monthly Cost (2026) Success / Response Rate
Trilostane (Vetoryl®) Oral medication, daily or twice daily PDH and adrenal tumors (first-line) Inhibits 3β-hydroxysteroid dehydrogenase, blocking cortisol synthesis in adrenal glands $40–$150/month depending on dog size and dose (30 mg, 60 mg, 120 mg capsules) Clinical improvement in 85–93% of dogs; symptom control typically within 2–4 weeks
Mitotane (Lysodren®) Oral medication, loading phase then maintenance PDH (alternative to trilostane) Selectively destroys the zona fasciculata and zona reticularis layers of the adrenal cortex $30–$80/month (maintenance); loading phase requires daily vet monitoring for 5–10 days 80–90% response rate; higher risk of adverse effects including Addisonian crisis if overdosed
Adrenalectomy Surgical removal of affected adrenal gland Adrenal tumors (benign or malignant, localized) Removes the cortisol-producing tumor entirely $2,500–$6,000 one-time (specialist surgery); may require 2–3 day hospitalization Curative for benign adenomas (90%+ long-term survival); malignant adenocarcinomas have ~50% 1-year survival due to metastasis risk
Hypophysectomy Surgical removal of the pituitary gland PDH (select cases, primarily at specialized centers) Removes the pituitary tumor driving adrenal overstimulation $5,000–$10,000+ one-time (performed at limited veterinary teaching hospitals and specialty centers) Remission rates of 70–85% in experienced centers; requires lifelong thyroid and desmopressin supplementation post-surgery
Radiation Therapy External beam radiation (stereotactic or fractionated) Pituitary macroadenomas (>10 mm) causing neurological signs Shrinks the pituitary tumor, reducing ACTH production and mass effect on the brain $4,000–$8,000 (course of treatment); may still need trilostane for cortisol control 70–80% improvement in neurological signs; tumor shrinkage over 3–12 months; does not always normalize cortisol
Steroid Withdrawal Gradual medication taper Iatrogenic Cushing's only Slowly reducing exogenous steroid allows adrenal glands to recover normal function Minimal direct cost; monitoring blood work $100–$200 per recheck Fully reversible in most cases over 3–6 months; underlying condition may require alternative treatment

Trilostane (Vetoryl®): The Current First-Line Standard

Since its FDA approval for veterinary use, trilostane has become the most widely prescribed medication for Cushing's disease in dogs. It works by reversibly inhibiting the enzyme 3β-HSD, which the adrenal glands need to synthesize cortisol. Unlike mitotane, trilostane does not destroy adrenal tissue, making it safer and more adjustable.

Dosing protocol: Trilostane is typically started at 1–2 mg/kg once daily with food (the drug is fat-soluble and absorption is significantly improved when given with a meal). Some dogs require twice-daily dosing for adequate 24-hour cortisol control. Your veterinarian will determine the starting dose based on your dog's weight and clinical presentation.

Monitoring schedule: ACTH stimulation tests are performed at 10–14 days, 30 days, 90 days, and then every 3–6 months for life. Blood work (chemistry panel and electrolytes) is checked at each visit. The goal is to maintain post-ACTH cortisol between 1.45–9.08 μg/dL (40–250 nmol/L), though target ranges may vary by laboratory and veterinary preference.

Side effects: Most dogs tolerate trilostane well. Mild side effects include occasional vomiting, diarrhea, or lethargy — these often resolve with dose adjustment. Serious adverse events are uncommon but can include an Addisonian crisis (acute adrenal insufficiency) characterized by sudden collapse, weakness, vomiting, and diarrhea. This is a medical emergency requiring immediate veterinary treatment with IV fluids and glucocorticoids.

Mitotane (Lysodren®): The Older Alternative

Mitotane works by selectively destroying the cortisol-producing layers of the adrenal cortex. Treatment involves a "loading phase" (daily dosing for 5–10 days until cortisol levels drop) followed by a "maintenance phase" (dosing 1–3 times per week). During the loading phase, owners must watch closely for signs of overdose: vomiting, diarrhea, lethargy, loss of appetite, or weakness. If these occur, the medication is stopped immediately and the veterinarian is contacted.

While mitotane is less expensive than trilostane on a per-dose basis, the intensive monitoring required during loading and the higher risk of adverse events make it a second-choice option in most current veterinary practices. It remains a valid alternative when trilostane is ineffective, unavailable, or cost-prohibitive.

Prognosis and Life Expectancy for Dogs with Cushing's Disease

Prognosis varies significantly based on the type of Cushing's disease, the presence of comorbidities, tumor size, and how early treatment begins. Below is a realistic breakdown based on current veterinary literature and data referenced by the American Kennel Club and peer-reviewed studies.

Disease Type Treatment Median Survival Time Key Prognostic Factors
PDH (microadenoma, <10 mm) Trilostane or Mitotane 2–2.5 years (many dogs live 3–5+ years with good management) Age at diagnosis, comorbidities (diabetes, infections), owner compliance with monitoring
PDH (macroadenoma, >10 mm) Radiation + trilostane 1–2 years (varies widely; some dogs stabilize for longer) Tumor size, neurological involvement, response to radiation
Adrenal Adenoma (benign) Adrenalectomy 3–4+ years (potentially curative; many dogs live a normal lifespan) Surgical complication rate (~10–20%), contralateral adrenal recovery
Adrenal Adenocarcinoma (malignant) Adrenalectomy ± chemotherapy 6–18 months (high metastasis rate to liver, lungs) Tumor invasion into vena cava, metastasis at time of diagnosis
Iatrogenic Cushing's Steroid taper Normal lifespan (fully reversible in most cases) Duration of steroid use, underlying disease requiring steroids

It is worth emphasizing: many dogs with PDH managed on trilostane live well beyond the median survival time, especially when diagnosed early and monitored consistently. The median reflects a population that includes dogs diagnosed at advanced stages with significant comorbidities. A healthy 8-year-old Poodle diagnosed early and treated diligently may live another 5–7 years — essentially a near-normal lifespan.

Home Care and Daily Management for Dogs with Cushing's Disease

Successful long-term management of Cushing's disease depends as much on consistent home care as on medication. Here is what daily life looks like for a dog undergoing treatment:

Medication Administration

  • Give trilostane at the same time(s) every day, always with a full meal. High-fat meals improve absorption — a spoonful of canned food or a small amount of peanut butter (xylitol-free) can help if your dog is a picky eater.
  • Never skip doses without consulting your veterinarian. Inconsistent dosing leads to cortisol fluctuations that worsen symptoms and complicate monitoring.
  • Keep a medication log: record the date, time, dose given, and any observed side effects (vomiting, lethargy, appetite changes). This log is invaluable during recheck appointments.

Water Access and Housebreaking Considerations

  • Even with treatment, many dogs continue to drink and urinate more than normal for the first several weeks. Ensure constant access to fresh water — never restrict water intake, as dehydration can be dangerous.
  • Increase potty break frequency during the initial treatment phase. Consider a doggy door, indoor potty pads, or a midday walker if you work long hours.
  • Most dogs see significant reduction in thirst and urination within 2–6 weeks of starting trilostane at the correct dose.

Diet and Weight Management

  • Feed a high-quality, AAFCO-approved diet appropriate for your dog's life stage. Moderate protein (20–30% on a dry matter basis), moderate fat, and controlled sodium are generally recommended.
  • Dogs with Cushing's are prone to muscle wasting, so adequate protein is important — avoid low-protein "senior" diets unless your veterinarian specifically recommends one for concurrent kidney disease.
  • Monitor body condition score (BCS) monthly. Aim for a BCS of 4–5/9. As muscle tone improves with treatment, your dog's caloric needs may change.
  • If your dog also develops diabetes (a common comorbidity), a veterinary nutritionist may recommend a high-fiber, complex-carbohydrate diet to help regulate blood glucose.

Monitoring and Recheck Schedule

After starting treatment, expect the following recheck schedule:

  • 10–14 days: ACTH stimulation test, chemistry panel, electrolytes — dose adjustment if needed
  • 30 days: Repeat ACTH stim, full blood work — further dose titration
  • 90 days: ACTH stim, blood work, blood pressure check — assess clinical response
  • Every 3–6 months thereafter: ACTH stim, CBC, chemistry, urinalysis, blood pressure — lifelong monitoring

Each recheck visit typically costs $150–$350, including exam fee and lab work. Budget approximately $600–$1,400 per year for ongoing monitoring once your dog is stabilized.

Skin and Coat Care

  • Hair regrowth is slow — expect 3–6 months before noticeable coat improvement. Some dogs never fully regrow their coat, especially if the hair follicles were damaged by prolonged cortisol excess.
  • Use gentle, moisturizing shampoos (oatmeal-based or veterinary-recommended) to support thin, fragile skin.
  • Treat secondary skin infections promptly with veterinarian-prescribed antibiotics or antifungals. Recurrent infections often signal that cortisol levels are not yet adequately controlled.

Cost Breakdown: Diagnosis, Treatment, and Lifetime Care

Cushing's disease is a significant financial commitment. Understanding the full cost picture helps you plan realistically and avoid treatment gaps that could harm your dog.

Expense Category Estimated Cost Range (USD) Frequency
Initial diagnostic workup (blood work, LDDST, ACTH stim, ultrasound) $600–$1,500 One-time
Advanced imaging (CT/MRI of brain) $1,000–$2,500 One-time (if needed)
Trilostane (Vetoryl) medication $40–$150/month Monthly, lifelong
Mitotane (Lysodren) medication $30–$80/month Monthly, lifelong
Monitoring visits (exam + ACTH stim + blood work) $150–$350 per visit 3–4 visits/year once stable
Adrenalectomy (specialist surgery) $2,500–$6,000 One-time (if applicable)
Hypophysectomy (specialist surgery) $5,000–$10,000+ One-time (if applicable)
Radiation therapy (for macroadenomas) $4,000–$8,000 One-time course
Emergency Addisonian crisis treatment $800–$2,500 As needed (uncommon but serious)
Estimated first-year total (PDH, medical management) $1,800–$4,500 —
Estimated annual ongoing cost (stabilized PDH) $1,000–$3,000 Per year, lifelong

Pet insurance considerations: If your dog was enrolled in a pet insurance plan before diagnosis, most comprehensive policies cover Cushing's disease diagnostics, medication, and monitoring. Annual benefit caps of $5,000–$10,000 are generally sufficient for medical management. If your dog is not yet insured and you are considering a breed at high risk, enrolling early (before any symptoms appear) is strongly recommended, as pre-existing conditions are universally excluded.

When to See the Vet: Emergency Red Flags

⚠ Seek Immediate Veterinary Care If Your Dog Shows:

  • Sudden collapse, severe weakness, or inability to stand — may indicate an Addisonian crisis (acute adrenal insufficiency), a life-threatening complication of both the disease and its treatment
  • Severe vomiting or diarrhea (especially with blood) — could signal Addisonian crisis, pancreatitis, or gastrointestinal ulceration
  • Difficulty breathing or rapid, labored breathing at rest — may indicate pulmonary thromboembolism (blood clot in the lungs), a known complication of hyperadrenocorticism
  • Neurological signs: head pressing, circling, seizures, sudden blindness, or severe disorientation — suggests a pituitary macroadenoma compressing brain tissue; requires urgent imaging
  • Acute abdominal distension with pain — could indicate organ rupture or severe pancreatitis
  • Excessive bleeding or bruising from minor trauma — may indicate a clotting disorder secondary to Cushing's

Always consult your veterinarian if you notice any new or worsening symptoms in a dog being treated for Cushing's disease. Dose adjustments, additional diagnostics, or emergency intervention may be needed. Never adjust your dog's trilostane or mitotane dose without veterinary guidance.

Prevention and Risk Reduction

There is no known way to prevent naturally occurring pituitary-dependent or adrenal Cushing's disease — the tumors that cause it arise spontaneously, and there is no genetic screening test available. However, you can take steps to reduce risk and catch the disease early:

  • Minimize unnecessary corticosteroid use: Work with your veterinarian to explore steroid-sparing alternatives for allergies, autoimmune conditions, and inflammatory diseases. Options include oclacitinib (Apoquel®), lokivetmab (Cytopoint®), cyclosporine, and targeted anti-inflammatory protocols. When steroids are necessary, use the lowest effective dose for the shortest possible duration.
  • Annual senior wellness screening: For dogs over 7 years old (especially in predisposed breeds), request annual blood work that includes a chemistry panel, CBC, and urinalysis. Elevated ALP and other early markers can flag Cushing's before overt symptoms develop.
  • Know your breed's risk profile: If you own a Poodle, Dachshund, Boston Terrier, or other high-risk breed, maintain heightened awareness for the early symptoms listed above and report them to your veterinarian promptly.
  • Regular weight and body condition monitoring: While obesity does not cause Cushing's disease, it can mask early symptoms and complicate both diagnosis and treatment.

Frequently Asked Questions

Can Cushing's disease in dogs be cured?

Adrenal tumors can sometimes be cured with surgical removal, particularly if the tumor is benign (adenoma). Pituitary-dependent Cushing's disease is generally not curable but is highly manageable with daily medication — most dogs achieve excellent symptom control and good quality of life for years. Hypophysectomy (pituitary surgery) offers a potential cure for PDH but is available at only a handful of specialized veterinary centers worldwide.

How long can a dog live with untreated Cushing's disease?

Without treatment, dogs with Cushing's disease face progressive organ damage. Median survival for untreated dogs is estimated at approximately 6–12 months after clinical signs become apparent, though some dogs survive longer. The primary causes of death in untreated cases include pulmonary thromboembolism, congestive heart failure, severe infections, diabetic ketoacidosis, and neurological complications from expanding pituitary tumors.

Is Cushing's disease painful for dogs?

Cushing's disease itself is not typically painful in the way that arthritis or cancer might be. However, the secondary effects — recurrent skin infections, muscle weakness, abdominal discomfort from organ enlargement, and joint stress from weight redistribution — can cause significant discomfort. Dogs with calcinosis cutis (calcium deposits in the skin) may experience skin irritation. Most owners report a dramatic improvement in their dog's energy and apparent comfort within weeks of starting treatment.

Are there natural or holistic treatments for Cushing's disease in dogs?

There is no scientifically validated natural cure for Cushing's disease. Some supplements marketed for "adrenal support" (such as melatonin, lignans from flaxseed, and ashwagandha) have been studied in limited contexts — melatonin may modestly help with hair regrowth, and flaxseed lignans have shown weak inhibitory effects on steroidogenic enzymes in laboratory settings. However, none of these replace trilostane or surgery as effective treatments. Always discuss any supplements with your veterinarian before adding them, as some can interfere with medication metabolism or monitoring tests.

What happens if I miss a dose of my dog's Cushing's medication?

Missing a single dose of trilostane is unlikely to cause a crisis, but cortisol levels will begin to rise, and you may notice a temporary return of symptoms (increased thirst, urination, or appetite). Give the next dose at the regular scheduled time — do not double up. If you miss more than two consecutive doses, contact your veterinarian, as a recheck ACTH stimulation test may be needed before resuming the medication. Chronic missed doses can lead to a full relapse of clinical signs.

Which breeds are most prone to Cushing's disease?

The breeds with the highest documented predisposition include Poodles (Miniature and Standard), Dachshunds, Boston Terriers, Yorkshire Terriers, Beagles, Bichon Frises, German Shepherds, and Labrador Retrievers. Small-breed dogs are generally overrepresented for pituitary-dependent Cushing's, while larger breeds have a somewhat higher incidence of adrenal tumors. Mixed-breed dogs can also develop Cushing's disease — no dog is immune.

This article is for informational purposes only and does not replace professional veterinary advice. If you suspect your dog has Cushing's disease, consult your veterinarian for proper diagnosis and an individualized treatment plan. For more information on endocrine disorders in dogs, the American Veterinary Medical Association provides owner-facing resources on common canine health conditions.

Written by

Marcus Aldridge

All our authors care for dogs every day — read more of their work on the authors page.